ATE74267T1 - Tiermedizinische behandlung. - Google Patents

Tiermedizinische behandlung.

Info

Publication number
ATE74267T1
ATE74267T1 AT87310749T AT87310749T ATE74267T1 AT E74267 T1 ATE74267 T1 AT E74267T1 AT 87310749 T AT87310749 T AT 87310749T AT 87310749 T AT87310749 T AT 87310749T AT E74267 T1 ATE74267 T1 AT E74267T1
Authority
AT
Austria
Prior art keywords
animal
antibacterial agent
veterinary treatment
treatment
prophylaxis
Prior art date
Application number
AT87310749T
Other languages
English (en)
Inventor
John Sidney Dowrick
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE74267(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE74267T1 publication Critical patent/ATE74267T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT87310749T 1986-12-10 1987-12-07 Tiermedizinische behandlung. ATE74267T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629481A GB8629481D0 (en) 1986-12-10 1986-12-10 Veterinary treatment
EP87310749A EP0271306B2 (de) 1986-12-10 1987-12-07 Tiermedizinische Behandlung

Publications (1)

Publication Number Publication Date
ATE74267T1 true ATE74267T1 (de) 1992-04-15

Family

ID=10608754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87310749T ATE74267T1 (de) 1986-12-10 1987-12-07 Tiermedizinische behandlung.

Country Status (15)

Country Link
EP (1) EP0271306B2 (de)
JP (1) JP2804970B2 (de)
KR (1) KR960001369B1 (de)
AT (1) ATE74267T1 (de)
AU (1) AU608262B2 (de)
CA (1) CA1326998C (de)
DE (1) DE3777973D1 (de)
DK (1) DK175763B1 (de)
ES (1) ES2036589T5 (de)
GB (1) GB8629481D0 (de)
GR (2) GR3005075T3 (de)
IE (1) IE62876B1 (de)
NZ (1) NZ222840A (de)
PT (1) PT86308B (de)
ZA (1) ZA879215B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813670D0 (en) * 1988-06-09 1988-07-13 Beecham Group Plc Veterinary composition
WO1994013261A1 (en) * 1992-12-08 1994-06-23 Bimeda Research And Development Limited Aqueous antibiotic composition for veterinary use
GB2334886B (en) 1996-12-18 2000-08-23 Bimeda Res Dev Ltd Antiinfective free intramammary veterinary composition
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
EP2962660A1 (de) 2004-02-02 2016-01-06 Bimeda Research & Development Limited Vorrichtung zur behandlung eines strichkanals eines tieres
CA2554717C (en) 2004-02-02 2013-10-29 Zoetis Broomhill Ip Limited Method and device for treating a teat canal of an animal
CN101107015B (zh) * 2005-01-19 2013-01-23 日本全药工业株式会社 乳腺炎用注入剂
WO2008045920A2 (en) 2006-10-10 2008-04-17 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US8272806B2 (en) * 2008-01-22 2012-09-25 Ford Contracting, Inc. Panel connector
BRPI1016082B1 (pt) 2009-04-08 2020-12-22 Wisconsin Alumni Research Foundation selante intramamário de mamilos
CN104622875B (zh) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法
EP4673211A1 (de) * 2023-03-01 2026-01-07 NEEO ApS Verfahren und system zur behandlung von rindermastitis
WO2025075087A1 (ja) * 2023-10-05 2025-04-10 沢井製薬株式会社 顆粒、顆粒を含む医薬品製剤、及び、顆粒を含む食品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB661970A (en) * 1948-04-07 1951-11-28 Bristol Lab Inc Improvements in or relating to penicillin preparations for injection
GB792545A (en) * 1955-07-27 1958-03-26 Novo Terapeutisk Labor As Manufacture of antibiotic preparations having a protracted effect
GB1312918A (en) * 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
JPS62185013A (ja) * 1986-02-08 1987-08-13 Green Cross Corp:The 易吸収性医薬組成物

Also Published As

Publication number Publication date
ZA879215B (en) 1988-10-26
PT86308A (en) 1988-01-01
EP0271306B2 (de) 1997-07-16
IE873334L (en) 1988-06-10
NZ222840A (en) 1990-10-26
DK644287A (da) 1988-06-11
CA1326998C (en) 1994-02-15
IE62876B1 (en) 1995-03-08
DK175763B1 (da) 2005-02-14
EP0271306B1 (de) 1992-04-01
AU608262B2 (en) 1991-03-28
DK644287D0 (da) 1987-12-08
ES2036589T5 (es) 1998-01-01
GR3024541T3 (en) 1997-12-31
AU8221787A (en) 1988-06-16
GB8629481D0 (en) 1987-01-21
EP0271306A2 (de) 1988-06-15
KR880007063A (ko) 1988-08-26
GR3005075T3 (en) 1993-05-24
PT86308B (pt) 1990-11-07
KR960001369B1 (ko) 1996-01-26
EP0271306A3 (en) 1989-06-14
DE3777973D1 (de) 1992-05-07
JPH01153625A (ja) 1989-06-15
JP2804970B2 (ja) 1998-09-30
ES2036589T3 (es) 1993-06-01

Similar Documents

Publication Publication Date Title
DE3777973D1 (de) Tiermedizinische behandlung.
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
NO932983L (no) Fettsyrebehandling
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
GR3018934T3 (en) Sustained release compositions for treating periodontal disease
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
FR2361116A1 (fr) Procede de prevention de la diarrhee chez les jeunes porcs et les jeunes veaux
EP0222712A3 (en) Veterinary compounds containing antimicrobial agents, and their use
CA2122780A1 (fr) Utilisation de la selegiline en medecine veterinaire
ATE59779T1 (de) Verfahren zur regulierung der tierischen fortpflanzung.
FR2682046B1 (fr) Casier homogeneisateur pour la conservation de doses d'insemination artificielle d'animaux tels que des truies.
ATE22389T1 (de) Verfahren zur anwendung ergotroper wirkstoffkombinationen in der aufzucht und mast von nutztieren.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
DE68900634D1 (de) Tiermedizinische zusammensetzung.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
ES263684Y (es) "jaula de pisos perfeccionada, para la cria y recria en avicultura".
BR9909791A (pt) Tratamento de distúrbios de ansiedade de modo geral com a partoxetina
IT8434840U1 (it) Gabbia per l'allevamento dei vitelli dopo il periodo dell'allattamento.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time